Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Cash from financing

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Dec 31, 2025-2,428+400.62%
Dec 31, 2024-485-108.32%
Dec 31, 20235,828-294.72%
Dec 31, 2022-2,993-124.81%
Dec 31, 202112,062-7.15%
Sep 30, 202112,991+7875.30%
Sep 30, 2020163-94.00%
Sep 30, 20192,714+17.08%
Sep 30, 20182,318+0.94%
Sep 30, 20172,296-1341.11%
Sep 30, 2016-185+4.44%
Sep 30, 2015-177-102.36%
Sep 30, 20147,499

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat